Cleared Traditional

K851247 - AMENDMENT LIFEPAK 200

K851247 is an FDA 510(k) clearance for AMENDMENT LIFEPAK 200, manufactured by Physio-Control Corp.. The device is a Class 2 Cardiovascular device with product code DRO cleared through the Traditional 510(k) pathway after a 43-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1985
Decision
43d
Days
Class 2
Risk

K851247 is an FDA 510(k) clearance for the AMENDMENT LIFEPAK 200, NPN 046. Classified as Pacemaker, Cardiac, External Transcutaneous (non-invasive) (product code DRO), Class II - Special Controls.

Submitted by Physio-Control Corp. (Redmond, US). The FDA issued a Cleared decision on April 19, 1985 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5550 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Physio-Control Corp. devices

FDA 510(k) Submission Details - K851247

510(k) Number K851247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 07, 1985
Decision Date April 19, 1985
Days to Decision 43 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 125d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRO Device Classification - Class 2, Special Controls

Product Code DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)

All 40
Devices cleared under the same product code (DRO) and FDA review panel - the closest regulatory comparables to K851247.
LIFEPAK 8 MODIFICATION
K853732 · Physio-Control Corp. · Dec 1985
EMERGIPACE - EXTERNAL PACEMAKER
K850812 · Life Science Instrumentation, Inc. · Nov 1985
PACEPAC
K852958 · Medical Data Electronics · Oct 1985
AMENDMENT LIFEPAK 100, NPN 045
K851248 · Physio-Control Corp. · Apr 1985
LIFEPAK 7D
K840047 · Physio-Control Corp. · Feb 1984
LIFEPAK 7P
K832876 · Physio-Control Corp. · Jan 1984